Active, Not Recruiting
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
NCT03613532
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States